Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Safety of Secukinumab from 1 Million Patient-Years of Exposure: Experience from Post-Marketing Setting and Clinical Trials.
Journal: Dermatology and therapy
Published: January 09, 2024
Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial.
Journal: The Lancet. Rheumatology
Published: February 01, 2023
Patient-reported impact of chronic urticaria compared with psoriasis in theUnited States.
Journal: The Journal of dermatological treatment
Published: September 01, 2016
Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: March 24, 2016
Showing 1-5 of 5
Last Updated: 09/26/2026